Ultragenyx Pharmaceutical Inc. (52) | Human Resources (11)

Browse by Subcategory

Recent Contracts

Form of Performance Stock Unit Agreement (2022) (Filed With SEC on May 6, 2022)
Amendment No. 1 to the Ultragenyx Pharmaceutical Inc. Deferred Compensation Plan (Filed With SEC on November 3, 2021)
Employment Inducement Plan (Filed With SEC on February 12, 2021)
Amendment No. 2 dated October 8, 2020 to the Transition Letter Agreement between Shalini Sharp and Ultragenyx Pharmaceutical Inc. dated as of March 5, 2020, as amended on August... (Filed With SEC on October 13, 2020)
Separation Agreement and General Release between Wladimir Hogenhuis, M.D. and Ultragenyx Pharmaceutical Inc., dated November 22, 2019 (Filed With SEC on November 25, 2019)
Ultragenyx Pharmaceutical Inc. Deferred Compensation Plan (Filed With SEC on August 3, 2021)
Form of Performance Stock Unit Agreement (2021) (Filed With SEC on May 5, 2021)
Amendment dated as of August 28, 2020 to Transition Letter Agreement between Shalini Sharp and Ultragenyx Pharmaceutical Inc. dated as of March 5, 2020 (Filed With SEC on September 2, 2020)
Form of Performance Stock Unit Agreement (2020) (Filed With SEC on May 7, 2020)
Transition Letter Agreement between Shalini Sharp and Ultragenyx Pharmaceutical Inc., dated March 5, 2020 (Filed With SEC on March 6, 2020)
Form of Performance Stock Unit Agreement (2019) (Filed With SEC on May 7, 2019)